David P. Meeker - President and CEO, Director at RHYTHM PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
RYTM on Nasdaq
All Insider Reports
All Insider Reports

David P. Meeker - trading volume in the past year for RHYTHM PHARMACEUTICALS, INC.

Holdings reported by David P. Meeker for RHYTHM PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 239,016 $26,050,353 $108.99 01 Feb 2026 Direct
Restricted Stock Units 71,900 $3,647,775 $57.22 11 Feb 2026 Direct Common Stock
Stock Options (Right to Buy) 107,850 11 Feb 2026 Direct Common Stock
Stock Option (Right to Buy) 0 03 Jun 2025 Direct Common Stock

Transactions reported by David P. Meeker for RHYTHM PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.